Article info
PDFResearch ethics
Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report
- Correspondence to: Dr O P Corrigan Centre for Family Research and Cambridge Genetics Knowledge Park, Faculty of Social and Political Sciences, University of Cambridge, Free School Lane, Cambridge, B2 3RF, UK; opc22cam.ac.uk
Citation
Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report
Publication history
- Received July 13, 2004
- Accepted July 27, 2004
- First published February 28, 2005.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by the Journal of Medical Ethics
Other content recommended for you
- Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study
- Adverse drug reactions of non-statin antihyperlipidaemic drugs in China from 1989 to 2019: a national database analysis
- Adverse drug reactions of statin therapy in China from 1989 to 2019: a national database analysis
- Influence of metabolic profiles on the safety of drug therapy in routine care in Germany: protocol of the cohort study EMPAR
- Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis
- Safety of ceftriaxone in paediatrics: a systematic review
- Adverse drug reactions in childhood: a review of prospective studies and safety alerts
- OHP-045 Incidence and risk factors of adverse drug reactions in the general population observed through an active pharmacovigilance project
- Study protocol for a multicentre, open-label, single-arm phase I/II trial to evaluate the safety and efficacy of ripasudil 0.4% eye drops for retinopathy of prematurity
- Clinical and economic impact of adverse drug reactions in hospitalised patients: prospective matched nested case–control study in Ethiopia